• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[罗伊氏乳杆菌SL001对AD模型小鼠和C57BL/6小鼠肠道微生物群的影响]

[Influence of Lactobacillus reuteri SL001 on intestinal microbiota in AD model mice and C57BL/6 mice].

作者信息

Liu Meimei, Hu Ruqian, Guo Yaowen, Sun Weizhong, Li Jiantao, Fan Mingliang, Wang Yan, Du Huamao, Tang Zhiru, Chai Chunli

机构信息

College of Biotechnology, Southwest University, Chongqing 400715, China.

College of Animal Science, Southwest University, Chongqing 400715, China.

出版信息

Sheng Wu Gong Cheng Xue Bao. 2020 Sep 25;36(9):1887-1898. doi: 10.13345/j.cjb.200024.

DOI:10.13345/j.cjb.200024
PMID:33164464
Abstract

We studied the influence of Lactobacillus reuteri SL001 (L. reuteri SL001) on the gut microbial community in Alzheimer's disease model mice (APP/PS1 double transgenic mice, ADmice) and wild type (C57BL/6) mice. The AD model mice and wild type mice were divided into test and control groups (4 in total), with 5 mice each and only male mice. The test group was fed with 0.2 mL suspension of L. reuteri SL001 at 5×10¹¹ CFU/mL. The control group received the same amount of sterile PBS daily for 45 days. Fecal samples were collected to compare and analyze the community structure and diversity of microbiota through high-throughput sequencing of the V3-V4 region of 16S rRNA gene. By sequence alignment and classification, the intestinal microbial OTUs of the 4 groups including 19 phyla, 40 classes, 64 orders, 104 families and 175 genera. The α diversity of AD model mice was greater than that of wild type mice, but the difference between the two was small. After adding L. reuteri SL001, the α diversity of both mice increased, and the increase in AD model mice was smaller. At the phyla level, the dominant phyla of the four groups of mice were Bacteroidetes, Firmicutes and Proteobacteria. The abundance of Bacteroides phylum in AD model mice was lower than that of wild type, and the abundance of chlamydomonas was higher than that of wild type. Feeding L. reuteri SL001 reduced the proportion of Firmicutes/Bacteroidetes (F/B) in mice. At the order level, the relative abundance of Bacteroidales, Lactobacillales, Bacillales and Bifidobacteriales in AD model mice was lower than that of wild type mice. At the genus level, the abundant genera were Allobaculum, Lachnospiraceae_NK4A136_group, Bacteroides and Lactobacillus. The relative abundance of Bacteroides, Lactobacillus, Bifidobacterium and Alloprevotella in AD model mice was lower than that in wild type mice. Adding L. reuteri SL001 increased the abundance of these genera and Bacteroides, Lactobacillus, Bacillus and Bifidobacteria in AD model mice. The relative abundance of Butyrivibrio in AD model mice was also lower than that in wild type, but after the feeding of L. reuteri SL001, the relative abundance was reduced in both mice. The dominant strains of wild-type mice were Lactobacillus, and no dominant flora was found in AD model mice. The results in this article provide valuable data for revealing the difference in intestinal microbial diversity between AD model mice and C57BL/6 mice, and feeding L. reuteri SL001 play positive roles in adjusting the intestinal bacterial community structure of AD model mice.

摘要

我们研究了罗伊氏乳杆菌SL001(L. reuteri SL001)对阿尔茨海默病模型小鼠(APP/PS1双转基因小鼠,AD小鼠)和野生型(C57BL/6)小鼠肠道微生物群落的影响。将AD模型小鼠和野生型小鼠分为试验组和对照组(共4组),每组5只且均为雄性小鼠。试验组小鼠每日灌胃0.2 mL浓度为5×10¹¹ CFU/mL的罗伊氏乳杆菌SL001悬液。对照组每天接受等量的无菌PBS,持续45天。收集粪便样本,通过对16S rRNA基因V3-V4区域进行高通量测序,比较和分析微生物群的群落结构和多样性。通过序列比对和分类,4组小鼠的肠道微生物OTU包括19个门、40个纲、64个目、104个科和175个属。AD模型小鼠的α多样性大于野生型小鼠,但两者差异较小。添加罗伊氏乳杆菌SL001后,两种小鼠的α多样性均增加,且AD模型小鼠的增加幅度较小。在门水平上,4组小鼠的优势菌门为拟杆菌门、厚壁菌门和变形菌门。AD模型小鼠中拟杆菌门的丰度低于野生型,衣原体的丰度高于野生型。饲喂罗伊氏乳杆菌SL001降低了小鼠中厚壁菌门/拟杆菌门(F/B)的比例。在目水平上,AD模型小鼠中拟杆菌目、乳杆菌目、芽孢杆菌目和双歧杆菌目的相对丰度低于野生型小鼠。在属水平上,优势属为别氏菌属、毛螺菌科_NK4A136_组、拟杆菌属和乳杆菌属。AD模型小鼠中拟杆菌属、乳杆菌属、双歧杆菌属和异普雷沃菌属的相对丰度低于野生型小鼠。添加罗伊氏乳杆菌SL001增加了AD模型小鼠中这些属以及拟杆菌属、乳杆菌属、芽孢杆菌属和双歧杆菌属的丰度。AD模型小鼠中丁酸弧菌属的相对丰度也低于野生型,但饲喂罗伊氏乳杆菌SL001后,两种小鼠中的相对丰度均降低。野生型小鼠的优势菌株为乳杆菌属,AD模型小鼠中未发现优势菌群。本文的研究结果为揭示AD模型小鼠与C57BL/6小鼠肠道微生物多样性差异提供了有价值的数据,且饲喂罗伊氏乳杆菌SL001对调节AD模型小鼠肠道细菌群落结构具有积极作用。

相似文献

1
[Influence of Lactobacillus reuteri SL001 on intestinal microbiota in AD model mice and C57BL/6 mice].[罗伊氏乳杆菌SL001对AD模型小鼠和C57BL/6小鼠肠道微生物群的影响]
Sheng Wu Gong Cheng Xue Bao. 2020 Sep 25;36(9):1887-1898. doi: 10.13345/j.cjb.200024.
2
Changes in the diversity and composition of gut microbiota of weaned piglets after oral administration of Lactobacillus or an antibiotic.断奶仔猪口服乳酸菌或抗生素后肠道微生物多样性和组成的变化。
Appl Microbiol Biotechnol. 2016 Dec;100(23):10081-10093. doi: 10.1007/s00253-016-7845-5. Epub 2016 Oct 19.
3
Dietary SL001 Improves Growth Performance, Health-Related Parameters, Intestinal Morphology and Microbiota of Broiler Chickens.日粮SL001改善肉鸡的生长性能、健康相关参数、肠道形态和微生物群。
Animals (Basel). 2023 May 19;13(10):1690. doi: 10.3390/ani13101690.
4
Effects of probiotics and prebiotics on intestinal microbiota in mice with acute colitis based on 16S rRNA gene sequencing.基于 16S rRNA 基因测序的益生菌和益生元对急性结肠炎小鼠肠道微生物群的影响。
Chin Med J (Engl). 2019 Aug 5;132(15):1833-1842. doi: 10.1097/CM9.0000000000000308.
5
DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites.DSM 17938 喂养健康的新生小鼠可调节免疫反应,同时调节肠道微生物群并增加有益代谢物。
Am J Physiol Gastrointest Liver Physiol. 2019 Dec 1;317(6):G824-G838. doi: 10.1152/ajpgi.00107.2019. Epub 2019 Sep 4.
6
Intestinal microecology in mice bearing diethylnitrosamine-induced primary hepatocellular carcinoma.二乙基亚硝胺诱导原发性肝癌小鼠的肠道微生态。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Aug 1;51(4):438-453. doi: 10.3724/zdxbyxb-2022-0283.
7
Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial.口服罗伊氏乳杆菌DSM 17938和PTA 5289 12周后的口腔微生物群变化:一项随机对照试验
PLoS One. 2015 May 6;10(5):e0125812. doi: 10.1371/journal.pone.0125812. eCollection 2015.
8
[Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].[16S核糖体RNA高通量测序技术分析特重度烧伤患者肠道微生物群的动态变化]
Zhonghua Shao Shang Za Zhi. 2020 Dec 20;36(12):1159-1166. doi: 10.3760/cma.j.cn501120-20200518-00271.
9
and differentially affect gut microbes and metabolites in mice with Treg deficiency.并且在 Treg 缺陷的小鼠中差异影响肠道微生物和代谢物。
Am J Physiol Gastrointest Liver Physiol. 2021 Jun 1;320(6):G969-G981. doi: 10.1152/ajpgi.00072.2021. Epub 2021 Mar 31.
10
Observation of the Gut Microbiota Profile in C57BL/6 Mice Induced by ANKA Infection.观察 ANKA 感染诱导的 C57BL/6 小鼠肠道微生物群特征。
Front Cell Infect Microbiol. 2021 Oct 28;11:680383. doi: 10.3389/fcimb.2021.680383. eCollection 2021.

引用本文的文献

1
in immunomodulation: molecular mechanisms and potential applications.在免疫调节:分子机制和潜在应用。
Front Immunol. 2023 Aug 9;14:1228754. doi: 10.3389/fimmu.2023.1228754. eCollection 2023.
2
Dietary SL001 Improves Growth Performance, Health-Related Parameters, Intestinal Morphology and Microbiota of Broiler Chickens.日粮SL001改善肉鸡的生长性能、健康相关参数、肠道形态和微生物群。
Animals (Basel). 2023 May 19;13(10):1690. doi: 10.3390/ani13101690.
3
Chromatin Accessibility and Transcriptional Landscape during Inhibition of by in IPEC-J2 Cells.
在 IPEC-J2 细胞中抑制 时的染色质可及性和转录景观。
Cells. 2023 Mar 22;12(6):968. doi: 10.3390/cells12060968.
4
Jiedu-Yizhi Formula Alleviates Neuroinflammation in AD Rats by Modulating the Gut Microbiota.解毒益智方通过调节肠道菌群减轻阿尔茨海默病大鼠的神经炎症。
Evid Based Complement Alternat Med. 2022 Jul 31;2022:4023006. doi: 10.1155/2022/4023006. eCollection 2022.
5
A Systematic Review on the Effects of Different Types of Probiotics in Animal Alzheimer's Disease Studies.不同类型益生菌在动物阿尔茨海默病研究中的作用的系统评价
Front Psychiatry. 2022 Apr 27;13:879491. doi: 10.3389/fpsyt.2022.879491. eCollection 2022.
6
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer's Disease.肠道微生物群在阿尔茨海默病患者中的作用及机制
Front Aging Neurosci. 2021 May 28;13:650047. doi: 10.3389/fnagi.2021.650047. eCollection 2021.